Rubén Hernández Alcoceba-rekin lankidetzan egindako argitalpenak (9)

2015

  1. Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model

    Gene Therapy, Vol. 22, Núm. 9, pp. 696-706

  2. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver

    Liver International, Vol. 35, Núm. 4, pp. 1274-1289

2013

  1. Target-mediated disposition model describing the dynamics of IL12 and IFNγ after administration of a mifepristone-inducible adenoviral vector for IL-12 expression in mice

    AAPS Journal, Vol. 15, Núm. 1, pp. 183-194

2011

  1. Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice

    Gut, Vol. 60, Núm. 3, pp. 341-349

  2. Self-inactivating helper virus for the production of high-capacity adenoviral vectors

    Gene Therapy, Vol. 18, Núm. 11, pp. 1025-1033

2009

  1. Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters

    Cancer Gene Therapy, Vol. 16, Núm. 9, pp. 703-712

  2. Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy

    Molecular Cancer, Vol. 8

2008

  1. Lethality in an anti-angiogenic tumor gene therapy model upon constitutive but not inducible expression of the soluble vascular endothelial growth factor receptor 1

    Journal of Gene Medicine, Vol. 10, Núm. 10, pp. 1083-1091

2007

  1. Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters

    Human Gene Therapy, Vol. 18, Núm. 8, pp. 681-690